REPORT HIGHLIGHT
Carboprost tromethamine market size was valued at USD 1,509.6 Million in 2022, expanding at a CAGR of 4.3% from 2023 to 2030.
Carboprost tromethamine also referred to as hemabate, is a prostaglandin used to treat postpartum hemorrhage and severe bleeding post-child delivery in females. Additionally, it is utilized as a contraceptive pill to induce abortion by gradual expulsion of the placenta and causing uterine contractions. The drug is provided anytime between the third and fifth month of the pregnancy. Increased contractions are the result of it working on the F receptor or the E2 receptor sites present in the uterine muscles.
Carboprost Tromethamine Market - Market Dynamics:
- The increasing prevalence of postpartum hemorrhage, government initiatives, and healthcare policies drives the market growth
- Postpartum hemorrhage is excessive bleeding after childbirth is a major cause of maternal morbidity and mortality worldwide. The growing use of prevalence of postpartum hemorrhage (PPH) is increasing the demand for drugs such as carboprost tromethamine that help to control and manage postpartum bleeding. Additionally, due to the high birthrate, postpartum hemorrhage cases also rise. Thus the rising prevalence of PPH will boost the global carboprost tromethamine market growth. However, the lack of highly skilled healthcare professionals is a reason to hamper the market demand. Moreover, healthcare and government organizations are enabling several initiatives to improve maternal healthcare and minimize maternal mortality. In line with this, it involves programs that focus on managing postpartum hemorrhage effectively. As a result, the initiatives increase the demand for drugs such as carboprost tromethamine, which will drive carboprost tromethamine market growth.
Carboprost Tromethamine Market - Key Insights:
- As per the analysis shared by our research analyst, the global carboprost tromethamine market is estimated to grow annually at a CAGR of around 4.3% over the forecast period (2023-2030)
- The carboprost tromethamine industry is projected to grow at a significant rate due to the rise of high birthrate, postpartum hemorrhage cases
- Based on product formulation segmentation, postpartum hemorrhage treatment was predicted to show maximum market share in the year 2022
- On the basis of region, North America was the leading revenue generator in 2022
Carboprost Tromethamine Market- Segmentation Analysis:
- The global carboprost tromethamine market is segmented on the basis of product formulation, application, distribution channel, and region.
- The market is divided into two categories based on product formulation: pregnancy abortion and postpartum hemorrhage treatment. The postpartum hemorrhage treatment segment is likely to maintain its dominance. The growth of the segment is attributed to the increasing prevalence of postpartum hemorrhage (PPH). Due to the increasing number of birth cases, there is also a rising incidence of postpartum hemorrhage.
- The market is divided into two categories based on application: powder for reconstitution and injectable formulation. The injectable formulation segment is accounted to witness speedy growth in the market. The injectable formulations are commonly used in clinical settings for controlled dosage administration and their quick onset of action. Additionally, the injectable form is often employed in emergencies, like postpartum hemorrhage, where effective and rapid treatment is essential.
- The market is divided into three categories based on distribution channels: online pharmacies, hospital pharmacies, and retail pharmacies. The hospital pharmacies segment is likely to possess the largest revenue share over the forecast period. Hospital pharmacies are an essential distribution channel for drugs like carboprost tromethamine. In addition, hospital pharmacies are likely to dispense and stock them as required, particularly in cases of postpartum hemorrhage or different medical issues requiring the use of this medication.
Carboprost Tromethamine Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Carboprost Tromethamine Market- Competitive Landscape:
Advances in the medical techniques and technology techniques for managing postpartum hemorrhage are expected to affect the market for medications like Carboprost Tromethamine. The market growth may also be influenced by other treatments or medications for similar indications. Moreover, major players are also adopting types of strategies such as collaboration, R&D activities, mergers & acquisitions, and partnerships. For instance, in February 2022, Amneal introduced that four generic injectables products are now approved. Moreover, azacitidine 100 mg, atropine sulfate injection, USP 0.5 mg/5 mL, carboprost tromethamine injection, USP 250 mcg/mL, and dexamethasone sodium phosphate injection, USP 10 mg/mL have received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA).
Recent Developments:
For instance, in March 2021, Sunny Pharmtech Inc. released a statement announcing that the US FDA approved its ANDA ("Abbreviated New Drug Application") of Carboprost Tromethamine Injection. Additionally, carboprost tromethamine Injection is indicated for aborting pregnancy.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CARBOPROST TROMETHAMINE MARKET KEY PLAYERS
- Taj Pharmaceuticals Limited
- Pfizer Inc.
- Apionex Pharma Pvt Ltd.
- MANUS AKTTEVA BIOPHARMA LLP
- Biosynth
- Monvi labs
- Amneal Pharmaceuticals LLC
- ChemScene
- Bio-Techne
- ANGUS Chemical Company
- WATSON INTERNATIONAL LIMITED
- SimSon Pharma Limited
- Ryvis Pharma
- Universal Biologicals
- Woodward Pharma
- Merck KGaA
- Dr. Reddy's Laboratories Ltd.
- BioSpectra Inc.
GLOBALCARBOPROST TROMETHAMINE MARKET, BY PRODUCT FORMULATION
- Pregnancy Abortion
- Postpartum Hemorrhage Treatment
GLOBAL CARBOPROST TROMETHAMINE MARKET, BY APPLICATION
- Powder for Reconstitution
- Injectable Formulation
GLOBAL CARBOPROST TROMETHAMINE MARKET, BY DISTRIBUTION CHANNEL
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
GLOBAL CARBOPROST TROMETHAMINE MARKET, BY REGION
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA